National Research (NASDAQ:NRC) Stock Passes Above Two Hundred Day Moving Average – Here’s Why

Shares of National Research Corporation (NASDAQ:NRC) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $15.84 and traded as high as $18.31. National Research shares last traded at $17.73, with a volume of 135,330 shares.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, March 6th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

National Research Stock Performance

The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 5.36. The firm has a market capitalization of $403.29 million, a P/E ratio of 35.46 and a beta of 0.53. The company’s 50 day moving average is $16.84 and its 200-day moving average is $15.84.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, February 3rd. The company reported $0.16 EPS for the quarter. The company had revenue of $35.19 million during the quarter. National Research had a return on equity of 103.84% and a net margin of 8.44%.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 10th. Stockholders of record on Friday, March 27th will be paid a $0.16 dividend. The ex-dividend date is Friday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.6%. National Research’s dividend payout ratio is presently 128.00%.

Hedge Funds Weigh In On National Research

Institutional investors have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC purchased a new position in shares of National Research in the first quarter worth about $118,000. AQR Capital Management LLC raised its holdings in National Research by 168.6% during the 1st quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock valued at $1,384,000 after acquiring an additional 67,882 shares during the period. Jane Street Group LLC lifted its position in shares of National Research by 394.2% during the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock worth $671,000 after acquiring an additional 41,806 shares in the last quarter. Strs Ohio purchased a new stake in shares of National Research during the first quarter worth $33,000. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of National Research by 1,072.5% in the second quarter. PNC Financial Services Group Inc. now owns 2,087 shares of the company’s stock worth $35,000 after acquiring an additional 1,909 shares during the period. Institutional investors own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.